Related Experiment Videos
Chinese medicinal herbs for influenza
Lanhui Jiang1, Linyu Deng, Taixiang Wu
1Chinese Evidence-Based Medicine Centre, West China Hospital, Sichuan University, Chengdu, China.
The Cochrane Database of Systematic Reviews
|April 2, 2013
Summary
Traditional Chinese medicinal herbs show potential for preventing and treating influenza, with some demonstrating efficacy comparable to antiviral drugs. However, current evidence is limited by study quality, necessitating further high-quality research.
Area of Science:
- Integrative Medicine
- Pharmacology
- Epidemiology
Background:
- Influenza poses a significant public health threat, causing high morbidity and mortality during epidemics.
- Traditional Chinese medicinal herbs are explored as potential therapeutic options for influenza management.
- Assessing the efficacy and safety of these herbal treatments is crucial for evidence-based practice.
Purpose of the Study:
- To evaluate the effectiveness of traditional Chinese medicinal herbs in preventing and treating influenza.
- To determine the frequency of adverse effects associated with these herbal interventions.
Main Methods:
- Systematic search of multiple databases (CENTRAL, MEDLINE, EMBASE, CNKI) and clinical trial registries.
- Inclusion of randomized controlled trials (RCTs) comparing Chinese medicinal herbs with placebo, no treatment, or conventional medicine.
- Independent data extraction and quality assessment by two review authors.
Main Results:
- 18 RCTs with 2521 participants were included; most studies (17) had poor methodological quality.
- Chinese medicinal herbs showed comparable efficacy to antiviral drugs in preventing influenza and alleviating symptoms in limited trials.
- Mild adverse reactions were reported in ten studies; 'Ganmao' capsules showed superiority over amantadine in one study.
Conclusions:
- Most Chinese medicinal herbs demonstrated similar effects to antiviral drugs for influenza prevention and treatment.
- Few herbs showed superiority, and no significant adverse events were reported, but evidence quality is weak.
- High-quality RCTs with larger sample sizes and clear reporting are needed to confirm efficacy and safety.